This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Seagon, S. Articles by Dürst, M. Search for Related Content PubMed PubMed Citation Articles by Seagon, S. Articles by Dürst, M.

Genetic Analysis of an in Vitro Model System for Human Papillomavirus Type 16-associated Tumorigenesis

Angewandte Tumorvirologie, Deutsches Krebsforschungszentrum (0615), Im Neuenheimer Feld 242, D-69120 Heidelberg, Germany

We have investigated the genetic basis for malignant progression of an human papillomavirus type 16 immortalized human keratinocyte cell line (HPKIA) by somatic cell fusion. In this cell culture model system for human papillomavirus type 16-associated tumorigenesis, early passage cells (HPKIA-nt) are nontumorigenic, whereas -irradiated late passage cells (HPKIA-t) are tumorigenic when tested in nude mice. Fusion of HPKIA-t cells with normal human keratinocytes or with HPKIA-nt gave rise to hybrid clones in which the tumorigenic phenotype is suppressed. This observation is in line with complementation studies conducted for other tumor cell systems and indicates that, also in the case of HPKIA-t cells, the tumorigenic phenotype is recessive. Hybrid clones derived by fusion of HPKIA-t with cells of the cervical carcinoma cell lines C4-I, HeLa, or C33A were also nontumorigenic. However, the tumorigenic phenotype was retained in all of the HPKIA-t x SiHa and HPKIA-t x MS751 hybrids tested. The cervical carcinoma cell lines SiHa and MS751, therefore, cannot complement the gene defect(s) related to tumor growth of HPKIA-t cells. This may suggest that HPKIA-t, SiHa, and MS751 cells share the same defect(s) in regulatory pathway(s) involved in tumor suppression. Differences in the steady state levels of viral E6–E7 transcripts were noted for most of the hybrid cells. The observations of this study underline the potential use of nontumorigenic and tumorigenic HPKIA cells to define genetic differences that may also correlate with tumor progression in vivo.

¹ To whom requests for reprints should be addressed.

Received 5/ 6/94. Accepted 8/31/94.

This article has been cited by other articles:

				M. Poignee, C. Backsch, K. Beer, L. Jansen, N. Wagenbach, E. J. Stanbridge, R. Kirchmayr, A. Schneider, and M. Durst Evidence for a Putative Senescence Gene Locus within the Chromosomal Region 10p14-p15 Cancer Res., October 1, 2001; 61(19): 7118 - 7121. [Abstract] [Full Text] [PDF]

				E. C. Goodwin, E. Yang, C.-J. Lee, H.-W. Lee, D. DiMaio, and E.-S. Hwang Rapid induction of senescence in human cervical carcinoma cells PNAS, September 26, 2000; 97(20): 10978 - 10983. [Abstract] [Full Text] [PDF]

				H. z. Hausen Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis J Natl Cancer Inst, May 3, 2000; 92(9): 690 - 698. [Abstract] [Full Text] [PDF]

				R. D. M. Steenbergen, J. N. Parker, S. Isern, P. J. F. Snijders, J. M. M. Walboomers, C. J. L. M. Meijer, T. R. Broker, and L. T. Chow Viral E6-E7 Transcription in the Basal Layer of Organotypic Cultures without Apparent p21cip1 Protein Precedes Immortalization of Human Papillomavirus Type 16- and 18-Transfected Human Keratinocytes J. Virol., January 1, 1998; 72(1): 749 - 757. [Abstract] [Full Text] [PDF]

				S. Solinas-Toldo, M. Durst, and P. Lichter Specific chromosomal imbalances in human papillomavirus-transfected cells during progression toward immortality PNAS, April 15, 1997; 94(8): 3854 - 3859. [Abstract] [Full Text] [PDF]